Mei Lu, PhD

Scientific Advisor

Biostatistican, professor of research at Henry Ford Health & Michigan State University and Director of Data Coordinating Center (DCC); over 30-year experience in DCC for multi-center clinical trials and network studies including FDA IND gene therapy trials for prostate cancers and FDA IDE biomarker trial for lung cancer prevention, Chronic hepatitis B and C cohort study (CHeCS) and Fibrotic Liver Disease (FOLD) Consortium cohort study of primary biliary cholangitis (PBC); co-authored 330 publication as to date.